Sam Brusco, Associate Editor06.18.24
Roche’s whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200) has earned U.S. Food and Drug Administration (FDA) 510(k) clearance.
The system is meant to help pathologists review and interpret digital images of scanned pathology slides to aid in patient diagnoses.
Digital pathology refers to digitalization of the traditional pathology workflow, beginning with slide scanning, to visualization, to analysis. Once the slide scanner captures and converts stained tissue on slides to visual images, the images can be managed, shared, and analyzed to help determine a cancer patient’s treatment.
Digital pathology aims to transform traditional histopathology by boosting efficiency, depth of analysis, and the opportunity for collaboration in pathology workflows. Roche’s end-to-end solution from tissue staining to producing high-quality digital images is assessed using automated artificial intelligence (AI)-based image analysis platforms.
Roch says its solution minimizes variables that can impact analysis. The company hopes to move the traditionally research-oriented tools into routine clinical practice.
"Primary diagnosis for digital pathology streamlines the digital workflow that empowers pathologists to make a timely diagnosis from anywhere," said Jill German, Head of Pathology Lab for Roche Diagnostics. "This not only improves a pathology lab's efficiency but also expands access to pathologists for people living in remote areas and increases opportunities for pathologists to collaborate on patient cases."
"We are investing in innovative digital pathology solutions to enable the pathology lab's digital transformation," German went on. "Artificial intelligence-based tools and our Roche Digital Pathology Open Environment are designed to drive greater adoption and promote innovation in this critical field."
The system is meant to help pathologists review and interpret digital images of scanned pathology slides to aid in patient diagnoses.
Digital pathology refers to digitalization of the traditional pathology workflow, beginning with slide scanning, to visualization, to analysis. Once the slide scanner captures and converts stained tissue on slides to visual images, the images can be managed, shared, and analyzed to help determine a cancer patient’s treatment.
Digital pathology aims to transform traditional histopathology by boosting efficiency, depth of analysis, and the opportunity for collaboration in pathology workflows. Roche’s end-to-end solution from tissue staining to producing high-quality digital images is assessed using automated artificial intelligence (AI)-based image analysis platforms.
Roch says its solution minimizes variables that can impact analysis. The company hopes to move the traditionally research-oriented tools into routine clinical practice.
"Primary diagnosis for digital pathology streamlines the digital workflow that empowers pathologists to make a timely diagnosis from anywhere," said Jill German, Head of Pathology Lab for Roche Diagnostics. "This not only improves a pathology lab's efficiency but also expands access to pathologists for people living in remote areas and increases opportunities for pathologists to collaborate on patient cases."
"We are investing in innovative digital pathology solutions to enable the pathology lab's digital transformation," German went on. "Artificial intelligence-based tools and our Roche Digital Pathology Open Environment are designed to drive greater adoption and promote innovation in this critical field."